References
- Cho JH. Advances in the genetics of inflammatory bowel disease. Curr Gastroenterol Rep 2004; 6: 467–73
- Lésage S, Zouali H, Cézard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype–phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845–57
- Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004; 18: 481–96
- Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;Suppl 170:2–6, discussion 16–9.
- Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 2003; 9: 281–9
- Karban A, Waterman M, Panhuysen CI, Dresner Pollack CL, Nesher S, Datta L, et al. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease. Am J Gastroenterol 2004; 99: 1134–40
- Laghi L, Costa S, Saibeni S, Bianchi P, Omodei P, Carrara A, et al. Carriage of CARD15 variants and smoking as risk factors for resective surgery in patients with Crohn's ileal disease. Aliment Pharmacol Ther 2005; 22: 557–64
- Laine ML, Murillo LS, Morré SA, Winkel EG, Pena AS, van Winkelhoff AJ. CARD15 gene mutations in periodontitis. J Clin Periodontol 2004; 31: 890–3